Zave

7 Topics Found
Zavesca Miglustat

Miglustat, sold under the brand name Zavesca, is a medication used to treat type I Gaucher disease (GD1). It was developed by Oxford GlycoSciences and is marketed by Actelion. Miglustat has been approved in the EU, Japan, and Canada for treating progressive neurological complications in people with Niemann–Pick disease, type C (NPC). It was approved for medical use in the European Union in November 2002,[4][5] and for medical use in the United States in J...

Zavegepant Drug Index

I just started taking zabella to treat fibromyalgia today i have a awful headache i was wondering if i can take the bu/apap to get rid of it. I took the zavella at 8 am ## I didn't find any interactions listed between the Savella and Fioricet. Learn more Savella details here. Learn more Fioricet details here. However, you should check with your doctor or pharmacist to be certain. Is there anything else I can help with?

1 REPLY Filed under Savella
Opfolda Miglustat

Miglustat, sold under the brand name Zavesca, is a medication used to treat type I Gaucher disease (GD1). It was developed by Oxford GlycoSciences and is marketed by Actelion. Miglustat has been approved in the EU, Japan, and Canada for treating progressive neurological complications in people with Niemann–Pick disease, type C (NPC). It was approved for medical use in the European Union in November 2002,[4][5] and for medical use in the United States in J...

Miglustat Drug Index

Miglustat, sold under the brand name Zavesca, is a medication used to treat type I Gaucher disease (GD1). It was developed by Oxford GlycoSciences and is marketed by Actelion. Miglustat has been approved in the EU, Japan, and Canada for treating progressive neurological complications in people with Niemann–Pick disease, type C (NPC). It was approved for medical use in the European Union in November 2002,[4][5] and for medical use in the United States in J...

Treatment for Type 1 Gaucher ## Zavesca contains the active ingredient Miglustat. Common side effects may include: nausea, back pain, constipation and weight loss. You can read more here: Do you have any other questions?

1 REPLY Filed under Zavesca
NDC 66215-201 NDC Database

Zavesca 100 mg Oral Capsule by Actelion Pharmaceuticals Us, Inc. ## Markings: OGT;918;100 ## Shape: Capsule ## Color: White ## Package Codes: 66215-201-90 ## Active Ingredients: Miglustat

Can't find what you're looking for?